Navigation Links
Genoptix Reports Operating Results for the Third Quarter and First Nine Months of 2010
Date:11/4/2010

ome for the third quarter of 2010 was $9.0 million, or 18% of revenue, compared to operating income of $16.4 million, or 32% of revenue, for the same period in 2009. The reduction in margins is primarily due to the increase in costs related to the new laboratory facility brought into service at the end of the second quarter of 2010, increases in personnel, and the reduction in changes in revenue accounting estimates.

Net income was $4.4 million for the third quarter of 2010, or $0.24 diluted earnings per share (EPS), based on 18.1 million weighted average common shares outstanding and a tax rate for the quarter of 52%. This compares to net income of $9.5 million for the third quarter of 2009, or EPS of $0.53, based on 18.0 million weighted average common shares outstanding and a tax rate of 43%.

Year-To-Date Results  Revenues for the first nine months of 2010 totaled $147.9 million, including a $3.8 million benefit from changes in accounting estimates resulting primarily from strong cash collections related to prior years. This is an increase of approximately 9% over revenues of $135.3 million for the comparable period in 2009, which included a $6.4 million benefit from similar changes in accounting estimates. When excluding changes in accounting estimates for each period, revenues for the first nine months of 2010 increased by approximately 12% year-over-year.

Gross profit for the first nine months of 2010 was $87.5 million, up from $84.7 million for the same period in 2009. As a percentage of revenues, 2010 year-to-date gross margin was 59% of revenues as compared to 63% of revenues for the first nine months of 2009. Operating income for the first nine months of 2010 was $29.0 million, or 19% of revenues, compared to operating income of $39.9 million, or 30% of revenues, for the same period in 2009. The reduction in margins is primarily due to the increase in costs related to the new laboratory facility brought into service at the en
'/>"/>

SOURCE Genoptix, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Genoptix Ranked 41st Fastest-Growing Company in North America on Deloittes 2010 Technology Fast 500™
2. Genoptix Announces Participation at the 2010 UBS Global Life Sciences Conference
3. Genoptix, Inc. to Announce First Quarter 2010 Financial Results
4. Genoptix, Inc. to Announce Fourth Quarter and Full-Year 2009 Financial Results
5. Genoptix Announces Participation at Deutsche Bank 2009 MedTools Investor Conference
6. Genoptix Reports Continued Strong Growth for the Third Quarter and First Nine Months of 2009
7. Genoptix, Inc. Announces Availability of MPL W515 L/K Mutation Analysis for MPD at 49th Annual American Society of Hematology (ASH) Meeting
8. Addus HomeCare Reports Third Quarter 2010 Results
9. Isis Reports Financial Results and Highlights for Third Quarter 2010
10. Amylin Pharmaceuticals Reports Third Quarter Financial Results
11. Nektar Therapeutics Reports Third Quarter 2010 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2015)... 4, 2015 PTC Therapeutics, Inc. (NASDAQ: PTCT ... for the first quarter ending March 31, 2015. ... In our first full quarter since the commercial launch, we ... treatment for nonsense mutation Duchene Muscular Dystrophy. We now have ... treatment since our last earnings call," stated Stuart W. ...
(Date:5/4/2015)... May 4, 2015 Transportation Insight, a ... electronics distributor client, DSI Systems Inc., are featured ... magazine in the cover story emphasizing technology ... The editorial illustrates how Transportation Insight ... manage the growth and success of DSI,s complex ...
(Date:5/4/2015)... The New York Times sought out medical insight ... Dr. Rod Rohrich . Kybella, recently approved by ... fat deposits under the chin. Photo - ... in Kybella, deoxycholic acid, dissolves the fat under the ... this area without surgery. "So many consumers don,t want ...
Breaking Medicine Technology:PTC Therapeutics Reports First Quarter 2015 Financial Results and Provides Corporate Update 2PTC Therapeutics Reports First Quarter 2015 Financial Results and Provides Corporate Update 3PTC Therapeutics Reports First Quarter 2015 Financial Results and Provides Corporate Update 4PTC Therapeutics Reports First Quarter 2015 Financial Results and Provides Corporate Update 5PTC Therapeutics Reports First Quarter 2015 Financial Results and Provides Corporate Update 6PTC Therapeutics Reports First Quarter 2015 Financial Results and Provides Corporate Update 7PTC Therapeutics Reports First Quarter 2015 Financial Results and Provides Corporate Update 8PTC Therapeutics Reports First Quarter 2015 Financial Results and Provides Corporate Update 9Transportation Insight's Latest Enterprise Logistics Technology Highlighted in Inbound Logistics Magazine 2Transportation Insight's Latest Enterprise Logistics Technology Highlighted in Inbound Logistics Magazine 3Dr. Rod Rohrich Provides Medical Expertise on Kybella 2Dr. Rod Rohrich Provides Medical Expertise on Kybella 3
... HASCO Medical, Inc. (OTC Bulletin Board: HASC ... serves patients in Alabama, Florida, and Mississippi, today announced ... subsidiary of HASCO Medical, has signed an agreement with ... of the agreement, SMM will be providing high-end rehabilitation chairs ...
... NEW YORK, Jan. 13, 2011 Reportlinker.com announces ... in its catalogue: Merck & ... http://www.reportlinker.com/p074950/Merck--Co-Inc-PharmaVitae-Profile.html IntroductionThis analysis examines ... Co. in the prescription pharmaceutical sector. The profile ...
Cached Medicine Technology:HASCO Medical Signs Agreement With the State of Alabama 2Reportlinker Adds Merck & Co., Inc.: PharmaVitae Profile 2
(Date:5/4/2015)... and Seattle, WA (PRWEB) May 04, 2015 ... formation of a collaboration to facilitate development of NM108, ... ophthalmic disorders that lead to blindness, including Diabetic Retinopathy. ... MiDROPS™ formulation platform developed by EyeCRO, which can deliver ... via a topical eyedrop. , Under the terms ...
(Date:5/4/2015)... Charlottesville, VA (PRWEB) May 04, 2015 Ticket ... tickets at the John Paul Jones Arena in Charlottesville, ... in the history of the music business and this beloved ... down. Paul McCartney, the former member of two legendary groups: ... decades in the music business since 2013 on the “Out ...
(Date:5/4/2015)... (PRWEB) May 04, 2015 New findings ... Brain Tumor Association (ABTA) show that people diagnosed with ... and treatment options, including clinical trials, at the time ... to make difficult decisions about their course of treatment. ... of the first nationwide brain tumor volunteer network, the ...
(Date:5/4/2015)... Pricing Healthcare announces it will ... patient receiving care at St. George Surgical Center ... be performed by July 15th, 2015, and the patient must ... front and forego the filing of insurance claims). , The ... year, and it devastates more and more individuals and families. ...
(Date:5/4/2015)... (PRWEB) May 04, 2015 Sheltering Arms ... Center from Hale House. The Mother Hale Learning Center ... affordable Early Childhood Education. Sheltering Arms will begin operating ... to be served by the center. , Opened in ... ages six weeks to five years, many of whom ...
Breaking Medicine News(10 mins):Health News:EyeCRO and NeuMedics Announce Collaboration to Utilize MiDROPS™ Technology for the Development of NM108 2Health News:EyeCRO and NeuMedics Announce Collaboration to Utilize MiDROPS™ Technology for the Development of NM108 3Health News:Paul McCartney Tickets at John Paul Jones Arena in Charlottesville, VA: Ticket Down Slashes Paul McCartney Ticket Prices in Charlottesville at the John Paul Jones Arena 2Health News:American Brain Tumor Association Poll Underscores Need for Greater Awareness and Education at Time of Diagnosis 2Health News:American Brain Tumor Association Poll Underscores Need for Greater Awareness and Education at Time of Diagnosis 3Health News:Pricing Healthcare to Pay a Patient's Bill for a Procedure at Utah Facility 2Health News:Pricing Healthcare to Pay a Patient's Bill for a Procedure at Utah Facility 3Health News:Sheltering Arms Acquires the Mother Hale Learning Center 2
... FRANCISCO, Calif., Oct. 5 Exelixis,Inc. (Nasdaq: EXEL ... of research and development, will present at the 2007,BIO ... (EDT) on,Wednesday, October 10, 2007. The presentation will ... page under Investors on the Exelixis website at, http://www.exelixis.com ...
... -- conference call and audio web cast on October 9, 2007 --, BELLEVILLE, ON, Oct. ... U.S. Department of Agriculture,(USDA) comment on a field trial for its E. coli O157:H7 cattle vaccine,during ... Conference Call & Audio Web Cast ... Tuesday, October 9, 2007 ...
... creating an effective drug: finding a chemical compound that ... then delivering it to the right place in the ... support from a $478,000, five-year CAREER award from the ... part of this problem. She is creating a modular, ...
... and ASSAGO MI, Italy, Oct. 5 GENICON,and SIAD ... strategic,partnership. Under this new partnership, SIAD Healthcare S.p.A. has ... SIAD Healthcare,S.p.A. will have a position on GENICON,s Board ... of Yale University. In August of 2006, GENICON ...
... experts say , , FRIDAY, Oct. 5 (HealthDay News) -- ... to eat no more than 12 ounces of fish ... have been confused, and fish consumption has dropped. , ... by the U.S. Food and Drug Administration and the ...
... job done, study shows , FRIDAY, Oct. 5 (HealthDay News) -- ... insects, a new study reveals. , Cycads, a group of plants ... years, look similar to ferns or palms but are not related ... coniferous tress such as pines and firs. , Reporting in the ...
Cached Medicine News:Health News:Developing a modular, nanoparticle drug delivery system 2Health News:Developing a modular, nanoparticle drug delivery system 3Health News:SIAD Healthcare S.p.A. Acquires Minority Ownership in GENICON 2Health News:Fish Safe for Pregnant Women to Eat 2Health News:Fish Safe for Pregnant Women to Eat 3
Prostate biopsy transducer....
Multi-frequency, HST, linear transducer with a longer (60mm) footprint. Available with puncture adapter and water path. This transducer incorporates ALOKAs exclusive Hemispheric Sound Technology and ...
... Linear high frequency ... breast and superficial ... exclusive Hemispheric Sound ... technologies. This multi-frequency ...
... an excellent choice for a ... wide scan angle. With muliple ... designed for a wide view ... versatility of this transducer provides ...
Medicine Products: